Why Should I Vote On BetterDistricts?

Polling is a powerful tool to help our elected officials determine how they should vote.

Standard polling methods don't give you the control that you deserve. With BetterDistricts you can show your representative exactly how strongly a bill is supported in your community.

Send a clear signal on how you want your government to work.

 

H.R. 6577 - Price Relief, Innovation, and Competition for Essential Drugs Act

Introduced: 2018-07-26
Bill Status: Referred to the House Committee on Energy and Commerce.
 
Summary Not Available

Full Text


115th CONGRESS
2d Session
H. R. 6577


    To amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 7 years.


IN THE HOUSE OF REPRESENTATIVES

July 26, 2018

    Ms. Schakowsky introduced the following bill; which was referred to the Committee on Energy and Commerce


A BILL

    To amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 7 years.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Price Relief, Innovation, and Competition for Essential Drugs Act” or the “PRICED Act”.

SEC. 2. Exclusivity period for brand name biological products.

(a) In general.—Section 351(k)(7)(A) of the Public Health Service Act (42 U.S.C. 262(k)(7)(A)) is amended by striking “12 years” and inserting “7 years”.

(b) Conforming changes.—Paragraphs (2)(A) and (3)(A) of section 351(m) of the Public Health Service Act (42 U.S.C. 262(m)) is amended by striking “12 years” each place it appears and inserting “7 years”.

(c) Applicability.—This Act and the amendments made by this Act apply only with respect to a biological product for which the reference product (as such term is used in section 351 of the Public Health Service Act (42 U.S.C. 262)) is licensed under subsection (a) of such section on or after the date of enactment of this Act.


Relevant News Stories And Blog Posts

Title Worth Reading

Vote on H.R. 6577

 

Activity in last 30 days